Sample Page
Author:
CDT Equity Inc.
Posted Date:
April 7, 2026
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
CDT Equity Inc.
April 7, 2026
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
CDT Equity Inc.
March 26, 2026
CDT Equity Inc. Announces Reverse Stock Split
CDT Equity Inc.
March 25, 2026
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
CDT Equity Inc.
March 23, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
CDT Equity Inc.
March 18, 2026
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
CDT Equity Inc.
March 12, 2026
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
CDT Equity Inc.
March 5, 2026
CDT Positions for Transformational Growth
CDT Equity Inc.
March 4, 2026
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
CDT Equity Inc.
February 24, 2026
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
CDT Equity Inc.
February 20, 2026
